Testing the safety of a new drug for advanced solid tumors
Part of Cancer clinical trials.
This trial tests an experimental drug called Hemay5087 for people with advanced solid tumors. It aims to find out if the drug is safe and how well it works, offering a possible option when standard treatments have failed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have advanced cancer that has not gotten better with standard treatments, or there is no standard treatment available.
- Your tumor must be measurable on a CT or MRI scan.
- Your last cancer treatment should have been at least 4 weeks ago, and you should have recovered from any side effects.
- You should be able to care for yourself and perform daily activities (ECOG score of 0-1).
- You must agree to use effective birth control during the study and for 6 months after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug, BA1203, for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if the drug is safe and whether it can help shrink tumors.
This trial tests a new drug called HRS-6208 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and if it can help shrink or control the cancer.
This early-phase study (Phase 1) tests Hemay181, a new cancer medicine, in people with advanced solid tumors that have not been controlled by standard treatment. The goal is to see how the medicine works in the body and whether it can shrink or control tumors safely.
This trial tests a new drug, Hemay181, for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it can shrink tumors and how safe it is.
This trial is testing an investigational drug called SYS6077 to see if it is safe and tolerable for people with advanced solid tumors that have not responded to standard treatments. The goal is to find out if this drug is a safe option for patients who have run out of other choices.
This trial studies a new drug called HW071021 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug can help shrink or control the cancer.
Hear when a new Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.